| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | VISO THERAPEUTICS INC. | 2256 WENDT CIR | NAPERVILLE | IL | 60564-4454 | WILL | USA | R41EY034062 | Development of a Peptide Therapy for Corneal Wound Healing | 000 | 1 | NIH | 11/6/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | VISO THERAPEUTICS INC. | 512 N MCCLURG CT APT 3601 | CHICAGO | IL | 60611-4122 | COOK | USA | R41EY034062 | Development of a Peptide Therapy for Corneal Wound Healing | 000 | 1 | NIH | 11/2/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $300,889 ) |
| | 2022 | 2022 | VISO THERAPEUTICS INC. | 512 N MCCLURG CT APT 3601 | CHICAGO | IL | 60611-4122 | COOK | USA | R41EY034062 | Development of a Peptide Therapy for Corneal Wound Healing | 000 | 1 | NIH | 8/24/2022 | $300,889 |
|
|
